Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$175.41 - $217.92 $46,132 - $57,312
-263 Reduced 12.03%
1,923 $416,000
Q4 2022

Jun 14, 2023

BUY
$204.38 - $296.82 $53,751 - $78,063
263 Added 13.68%
2,186 $449 Million
Q4 2022

Mar 30, 2023

BUY
$204.38 - $296.82 $10,014 - $14,544
49 Added 2.29%
2,186 $449,000
Q4 2022

Feb 15, 2023

BUY
$204.38 - $296.82 $10,014 - $14,544
49 Added 2.29%
2,186 $449,000
Q3 2022

Jun 14, 2023

BUY
$195.21 - $310.53 $41,774 - $66,453
214 Added 11.13%
2,137 $594 Million
Q3 2022

Mar 30, 2023

BUY
$195.21 - $310.53 $3,904 - $6,210
20 Added 0.94%
2,137 $594,000
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $3,904 - $6,210
20 Added 0.94%
2,137 $594,000
Q2 2022

Jun 20, 2023

BUY
$115.91 - $214.48 $22,486 - $41,609
194 Added 10.09%
2,117 $404,000
Q1 2022

Jun 20, 2023

BUY
$127.96 - $207.36 $24,824 - $40,227
194 Added 10.09%
2,117 $438,000
Q1 2022

Mar 30, 2023

SELL
$127.96 - $207.36 $827,517 - $1.34 Million
-6,467 Reduced 75.34%
2,117 $438,000
Q1 2022

May 12, 2022

SELL
$127.96 - $207.36 $827,517 - $1.34 Million
-6,467 Reduced 75.34%
2,117 $439,000
Q4 2021

Jun 21, 2023

BUY
$165.13 - $241.83 $1.1 Million - $1.61 Million
6,661 Added 346.39%
8,584 $1.53 Million
Q4 2021

Mar 30, 2023

SELL
$165.13 - $241.83 $42,768 - $62,633
-259 Reduced 2.93%
8,584 $1.53 Million
Q4 2021

Feb 15, 2022

SELL
$165.13 - $241.83 $42,768 - $62,633
-259 Reduced 2.93%
8,584 $1.53 Million
Q3 2021

Jun 21, 2023

BUY
$163.99 - $235.57 $1.13 Million - $1.63 Million
6,920 Added 359.85%
8,843 $1.82 Million
Q3 2021

Mar 30, 2023

SELL
$163.99 - $235.57 $58,544 - $84,098
-357 Reduced 3.88%
8,843 $1.82 Million
Q3 2021

Nov 15, 2021

SELL
$163.99 - $235.57 $58,544 - $84,098
-357 Reduced 3.88%
8,843 $1.82 Million
Q2 2021

Jun 21, 2023

BUY
$131.45 - $201.49 $956,561 - $1.47 Million
7,277 Added 378.42%
9,200 $1.75 Million
Q2 2021

Mar 30, 2023

BUY
$131.45 - $201.49 $176,011 - $269,795
1,339 Added 17.03%
9,200 $1.75 Million
Q2 2021

Aug 16, 2021

BUY
$131.45 - $201.49 $1.21 Million - $1.85 Million
9,192 Added 114900.0%
9,200 $1.75 Million
Q1 2021

Jun 26, 2023

BUY
$92.73 - $142.05 $550,630 - $843,492
5,938 Added 308.79%
7,861 $1.02 Billion
Q1 2021

Mar 30, 2023

SELL
$92.73 - $142.05 $32,362 - $49,575
-349 Reduced 4.25%
7,861 $1.02 Million
Q1 2021

May 14, 2021

SELL
$92.73 - $142.05 $760,571 - $1.17 Million
-8,202 Reduced 99.9%
8 $1.02 Million
Q4 2020

Jun 22, 2023

BUY
$67.44 - $103.72 $423,995 - $652,087
6,287 Added 326.94%
8,210 $851,000
Q3 2020

Jun 26, 2023

BUY
$42.79 - $75.8 $269,020 - $476,554
6,287 Added 326.94%
8,210 $622,000
Q3 2020

Mar 30, 2023

SELL
$42.79 - $75.8 $7,274 - $12,886
-170 Reduced 2.03%
8,210 $622,000
Q3 2020

Nov 13, 2020

SELL
$42.79 - $75.8 $7,274 - $12,886
-170 Reduced 2.03%
8,210 $622,000
Q2 2020

Jun 26, 2023

BUY
$27.25 - $47.53 $175,953 - $306,901
6,457 Added 335.78%
8,380 $396,000
Q2 2020

Mar 30, 2023

BUY
$27.25 - $47.53 $7,466 - $13,023
274 Added 3.38%
8,380 $396,000
Q2 2020

Aug 14, 2020

BUY
$27.25 - $47.53 $7,466 - $13,023
274 Added 3.38%
8,380 $397,000
Q1 2020

Jul 12, 2023

BUY
$23.16 - $47.74 $143,198 - $295,176
6,183 Added 321.53%
8,106 $268,000
Q4 2019

Jul 12, 2023

BUY
$29.4 - $44.98 $181,780 - $278,111
6,183 Added 321.53%
8,106 $356,000
Q4 2019

Mar 30, 2023

BUY
$29.4 - $44.98 $154,232 - $235,965
5,246 Added 183.43%
8,106 $356,000
Q4 2019

Feb 14, 2020

BUY
$29.4 - $44.98 $154,232 - $235,965
5,246 Added 183.43%
8,106 $356,000
Q3 2019

Jul 12, 2023

BUY
$29.71 - $55.23 $27,838 - $51,750
937 Added 48.73%
2,860 $85,000
Q3 2019

Mar 30, 2023

BUY
$29.71 - $55.23 $20,024 - $37,225
674 Added 30.83%
2,860 $85,000
Q3 2019

Nov 14, 2019

BUY
$29.71 - $55.23 $84,970 - $157,957
2,860 New
2,860 $86,000
Q2 2019

Jul 12, 2023

SELL
$29.73 - $66.02 $38,619 - $85,759
-1,299 Reduced 67.55%
624 $35.6 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.